We describe a method to enhance the sensitivity of eukaryotic cDNA detection in differential display (DD) 
INTRODUCTION
Differential display (DD) is a widely used, effective method for identifying differentially expressed genes between similar cells or tissue types (2) . DD is an RT-PCR-based method that allows the visualization of cDNA fragments for comparison between samples on a high-resolution polyacrylamide gel. Significant improvements have been made to minimize the number of false positives and facilitate the cloning of PCR products (1, 3, 5, 8) . However, the amount of the RNA required as starting material may limit the use of DD.
We provide evidence that the addition of bacterial RNA to limited amounts of eukaryotic RNA before reverse transcription increases the sensitivity of DD tenfold. This method improves DD where problems exist with eluting and reamplifying bands that are otherwise of low intensity. E. coli RNA appears to either preserve the integrity of RNA or enhance the enzymatic reactions during RT-PCR by providing a nonspecific carrier for eukaryotic RNA. Because DD requires a polyadenylate tail that is generally absent in prokaryotic RNA, the oligonucleotide deoxythymidine (dT) primers do not efficiently hybridize with the bacterial RNA, and bacterial markers are not efficiently amplified. Despite the absence of the poly(A) tail in prokaryotic RNA, a limited amount of priming occurs that produces a specific DD pattern. The background pattern obtained from E. coliRNA is readily distinguishable from the eukaryotic gene pattern, and it may represent the low-affinity internal poly(A) track hybridization and reverse transcription.
One of the applications of DD in our laboratory is to identify cancer markers and expression changes in cells treated with chemotherapeutic agents. Therefore, we have applied DD to two different cancer cell lines. MCF7 breast cancer cells were exposed to two hybrid polar compounds that have been shown to inhibit histone deacetylases (9, 10) . We also used untreated LNCaP prostate cancer cells. In both tumor cell lines, E. coli RNA increased the cDNA detection levels. Additionally, we used differentially expressed mRNAs for the isolation of specific eukaryotic genes.
MATERIAL AND METHODS

Cell Culture
MCF7 cells were grown in DMEM supplemented with 10% fetal calf serum (FCS), penicillin (50 U/mL) and streptomycin (50 mg/mL). The cells were treated with 4 mM of the hydroxamic acid-based hybrid polar compound m-carboxycinnamic acid bis-hydroxamide (CBHA) or suberoylanilide hydroxamic acid (SAHA) in dimethyl sulfsoxide (DMSO) for 24 h (8, 9) . Control cells were treated with an equal amount of DMSO. LNCaP cells were maintained in RPMI containing 10% FCS, penicillin (50 U/mL) and streptomycin (50 mg/mL). The E. coli strain, JM109, was grown exponentially in LB broth at 35°C.
RNA Preparation
MCF7 and LNCaP cells were harvested, centrifuged at 500 × gfor 5 min at 4°C and washed in PBS. Total RNA was isolated from MCF7 and LNCaP cells using Trizol ® reagent (Life Technologies, Gaithersburg, MD, USA). For E. coli RNA isolation, the cells were grown exponentially, harvested by centrifugation at 1000 × gand resuspended in TE buffer (50 mM Tris, pH 7.5, 1 mM EDTA). The cells were treated with lysozyme and the RNA was extracted according to the RNeasy ® protocol (Qiagen, Valencia, CA, USA). Aliquots of LNCaP and E. coli RNA were digested to eliminate residual DNA with DNase I using the Message Clean ™kit (amplification grade; Life Technologies). The RNA was reprecipitated and resuspended in diethyl pyrocarbonate-treated (DEPC) water for DD analysis.
Differential Display
DD was performed using the RNAimage ® kit (GenHunter, Nashville, TN, USA) and with methods and primers previously described in our laboratory (4) . Anchor primers were HT11C (5 ′ -AAGCTTTTTTTTTTTC-3 ′ ) or LT11C (5 ′ -TGCCGAAGCTTTTTTTTTTTC-3 ′ ) and arbitrary primers were H-AP3 (5 ′ -AAGCTTTGGTCAG-3 ′ ), H-AP5 (5 ′ -AAGCTTAGTAGGC-3 ′ ), or E1-OPA-1 (5 ′ -C GTGAA T TCGCA GGC -CC TTC-3 ′ ). MCF7 and LNCaP RNA were diluted to 0 For greater stringency, a two-step PCR protocol was followed for the LT11C/E1-OPA-1 primer combination. A low-stringency cycle of 94°C for 1 min, 40°C for 4 min and 72°C for 1 min was performed and followed by 35 high-stringency cycles of 94°C for 1 min, 60°C for 4 min and 72°C for 1 min. For either low or high stringency, the PCRs contained PCR buffer (10 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 and 0.001% gelatin), 0.2 µ M primers, 2 µ M dNTP, 1/10 vol/vol of the reverse transcription reaction, 20 Ci/mmol of α -[ 33 P]dATP and 0.05 U/ µ L AmpliTaq ® DNA polymerase (PE Biosystems) in the reaction mixture. PCRs were electrophoresed on extended-format denaturing 6% polyacrylamide gels using the programmable GenomyxLR ™DNA Sequencer (Beckman Coulter, Fullerton, CA, USA).
Reamplification of cDNA
Bands were excised from dried differential display gels with a sterile blade and then rehydrated in 100 µ L of TE buffer (10 mM Tris-Cl, pH 7.6, 1 mM EDTA, pH 8.0) or 2 ×PCR buffer (20 mM Tris-Cl, pH 8.4, 100 mM KCl, 3 mM MgCl 2 and 0.002% gelatin) at room temperature for 10 min. Samples were boiled for an additional 15 min, and the DNA was reprecipitated. Reamplification was carried out using the same primer combination and conditions in PCR buffer (10 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 and 0.001% gelatin), 20 µ M dNTP and 0.05 U/ µ L AmpliTaq DNA polymerase.
Sequencing and Analysis
Automated sequencing of isolated DNA was done by the Dana-Farber Molecular Biology Core Facility. Sequences were analyzed using BLAST and PILEUP (Genetics Computer Group, Madison, WI, USA).
RT-PCR
We performed the reverse transcription of specific gene fragments using 2 µ g of total RNA from MCF7 cells, which were diluted in a total of 20 µ L and denatured at 75°C for 5 min, then placed on ice. The reverse transcription reaction consisted of 1.5 µ M oligonucleotide (dT) 12-18, buffer, (25 mM Tris-Cl, pH 8.3, 37.2 mM KCl, 1.5 mM MgCl 2 , 5 mM DTT), 0.5 mM dNTPs, RNase inhibitor 0.8 U/ µ L and 10 U/ µ L of S UPERSCRIPT II in a final volume of 30 µ L. Samples were incubated at 42°C for 1 h followed by 10 min at 80°C. Dilutions of the cDNA reactions were used for PCR with 0.2 µ M of KIAA0128-specific primers (5 ′ -GATACTCAGC -CAGTAGCTCA-3 ′ and 5 ′ -GGCATG -CCTTCGTTTTGCCA-3 ′ , sense and antisense, respectively) in a final 50 µ L PCR containing PCR buffer (10 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 and 0.001% gelatin), 0.02 mM dNTP, 2-4 µ L of cDNA from the RT mixture, and 10 U AmpliTaq DNA polymerase. PCR from control and drugtreated MCF7 cells were run on a 1.5% agarose gel. The quantification of the RT-PCR products was done using MultiAnalyst version 1.0.2 software (Bio-Rad Laboratories, Hercules, CA, USA). The bands were scanned to obtain numerical values from the RT-PCR agarose gel. The gel was stained with ethidium bromide, viewed by UV light and the image was directly analyzed by scanning with a densitometer Model GS-700 (Bio-Rad Laboratories). Two independent experiments were done (n=2).
RESULTS
Under standard DD conditions with 0.2 µ g RNA and primers HT11C and H-AP3, we were able to detect a number of differences in expression between the histone deacetylase inhibitors CBHA-or SAHA-treated and untreated MCF7 cells ( Figure 1A) . After excision and reamplification, one band was identified as the KIAA0128 gene. The 425 amino acid protein has 60.5% homology to human CDC10, a cell cycle protein that has been implicated in activating histone mRNA synthesis.
To confirm the expression differences of the newly identified gene KIAA0128 between the control and CBHA-or SAHA-treated MCF7 cells, we peformed RT-PCR using serial dilutions of cDNA. In Figure 1B , a representative RT-PCR is shown for KIAA-0128 with a GAPDH loading control. independent experiments. The volume of the bands for G3PDH (450 bp) was used to correct for the amount of DNA present in each reaction, assuming that this housekeeping gene expression does not change after treatment with either of the two drugs.
To determine if DD of this particular differentially displayed marker could be made more sensitive, dilutions of control and drug-treated MCF7 RNA were reverse transcribed for DD in the presence or absence of 6 µ g of E. coli RNA. In the absence of E. coli , no products were seen at the 0.016 µ g RNA level ( Figure 1C ). In the presence of 6 µg of the bacterial RNA, a pattern comparable to the original 0.2 µ g RNA pattern was generated. The expression difference of the KIAA0128 gene between drug-treated and untreated MCF7 was also maintained with the addition of E. coli RNA.
To confirm the origin of selected DD bands and to test for possible crosscontamination, a number of prokaryotic and eukaryotic-specific bands were excised from the DD gels, sequenced and subjected to a BLAST search. The queries confirmed matches with prokaryotic and eukaryotic-specific genes, respectively. There was no bacterial contamination of eukaryotic specific cDNA bands or vice versa (data not shown). The E. coli patterns obtained with any of the two oligonucleotide dT primers used (for low-stringency DD, HT11C and for high -stringency DD, LT11C) revealed that some specific priming can still occur using the S UPER -SCRIPT reverse transcription. Therefore, suitable control lanes containing E. coli RNA alone need to be run simultaneously to assess for low-specificity priming. The background obtained for E. coli RNA in either low or high-stringency DD could not be eliminated by using other non-poly(A) tailed RNA sources because the cDNA bands may represent internal poly(A) tracks randomly present within RNA sequences.
To broaden the application of the addition of E. coli RNA and increase the sensitivity of DD, we tested both LNCaP prostate cancer cells and different primer combinations. Under these different conditions, we observed a more prominent E. coli background. To reduce this background, DNase I-treated RNA was used for DD under low-stringency PCR conditions (Figure 2A ). This did not significantly reduce the number of E. coli cDNA bands. Both DNase Itreated and untreated E. coli RNA were able to increase the sensitivity of detection of LNCaP-specific cDNA.
However, when high-stringency DD was performed, DNase I treatment effectively decreased the E. colibackground ( Figure 2B ). With the combination of longer primers and higher stringency PCR conditions, both the bacterial and LNCaP background were significantly reduced, and the beneficial effects of E. coli RNA were maintained. At the 0.01 µ g of LNCaP RNA, we observed no DD signal in the absence of E. coli , as before. We observed an approximate 20-fold increase in sensitivity in the presence of E. coli RNA. At this level, the LNCaP pattern is visible.
DISCUSSION
A tenfold more sensitive expression of eukaryotic messages was observed in DD with the addition of 6 µ g E. coli RNA at the time of reverse transcription (Figures 1 and 2 ). The addition of E. coli RNA to 0.016 µ g, either from MCF7, drug-treated MCF7 or LNCaP RNA, allowed visualization of the pattern produced. The cDNA DD patterns obtained from 0.2 µ g of RNA of eukaryotic samples with no E. coli added were very similar. Additionally, bacterial RNA treated with DNase I and subjected to more stringent PCR conditions after reverse transcription with the eukaryotic RNA revealed clearly the cDNA bands and minimized bacterial background.
We were interested in the effect of E. coli on retaining pattern differences between samples. Gene-specific RT-PCR confirmed the up-regulation of the KIAA0128 gene in CBHA-and SAHA-treated MCF7 cells. The expression difference observed at 0.016 µ g MCF7 RNA reverse transcribed in the presence of E. coli RNA was equivalent to the DD pattern obtained at 0.2 µ g MCF7 RNA without E. coli treatment. In other cases, the addition of E. coli RNA could increase the clarity of otherwise low-intensity bands while maintaining differences in expression between samples.
To understand the nature of the effect, we added intact E. coli cells to various amounts of eukaryotic cells, centrifuged together, and we used the prepared RNA for cDNA synthesis. The results obtained by adding E. coli cells showed a similar effect as generated by the addition of E. coli RNA (data not shown). This indicated that the carrier effect of the bacterial cells during the RNA isolation was not responsible for the increase in sensitivity in the detection level. Genomic bacterial DNA added to the reverse transcription reaction or RNA added after the reverse transcription reaction did not reveal an increase in sensitivity of detection of the eukaryotic RNA. Therefore, the overall increase in sensitivity is more likely from an enhancement of the reverse transcription reaction either by preserving the integrity of eukaryotic RNA or by enhancing the enzymatic reaction. The presence of bacterial RNA could also alter the ionic strength and pH optimizing the enzymatic reaction.
The sites that are targets for the reverse transcription using bacterial RNA may correspond to internal poly(A) tracks. Such priming is the result of the low specificity of the reverse transcription enzyme. The more specific priming to the poly(A) tail of the eukaryotic RNA, the less background would be found. Therefore, the bacterial RNA is not a competitive substrate for the enzyme to generate cDNAs from poly(A) tails. One possible explanation on how the non-substrate bacterial RNA increases the reverse transcription of eukaryotic RNA may be by providing associations between RNAs from different sources and eliminating difficult secondary structures that are otherwise present in the template RNA. The increase in sensitivity may come from the results of the RNA interactions. An alternative explanation is that bacterial RNA protects the eukaryotic RNA from enzymatic degradation processes during the reverse transcription reaction. We did not find that the addition of E. coli RNA contaminated the cDNA fragments analyzed.
Also, for a differentially displayed cDNA, the addition of E. coli RNA was able to preserve and enhance it. This was the case for the differentially expressed KIAA0128 gene, a cell cycle protein that has been implicated in activating histone mRNA synthesis. The KIAA0128 gene potentially contains N-glycosylation sites and myristylation sites, which suggests a possible membrane anchoring function (6, 7, 11) , but its function in mammalian cells has not been described. The up-regulation of KIAA0128 gene may be related to the cell cycle arrests observed after 24 h of treatment with these drugs in LNCaP cells (data not shown), and therefore, future efforts to understand the role of this gene in the cell cycle control could be developed.
In summary, E. coli RNA enhances to tenfold the sensitivity of DD when added to eukaryotic RNA at the time of reverse transcription. The addition of E. coli RNA at the optimal concentrations did not seriously modify the eukaryotic cDNA pattern. Eukaryotic RNA successfully interacts with E. coli RNA to produce a true expression pattern of the eukaryotic sample and maintains differences in expression between samples. The application of this modifed technique to samples containing limited amounts of RNA should increase the success of DD in such situations.
INTRODUCTION
Green fluorescent protein (GFP) has enjoyed widespread use as a qualitative reporter of in vivo gene expression in prokaryotes and eukaryotes (9,13). Surprisingly few studies have reported the use of GFP as a quantitative reporter of promoter activity in prokaryotes (5, 7, 11, 14) . In contrast, β -galactosidase ( β -gal) has been used extensively as a reporter for quantifying gene expression in Escherichia coli . The ease of use of GFP makes it an attractive candidate as a reporter of promoter strength in E. coli .
Numerous variants of GFP are available (13). We chose to work with GFPuv because it offers several advantages over wild-type GFP: it is more soluble at high expression levels, less toxic and yields more intense fluorescence (3). (From this point, we will refer to GFPuv simply as GFP.)
To test the utility of GFP as a quantitative reporter, we constructed a promoterless GFP vector into which we inserted a series of previously studied synthetic promoters having varying activities (Table 1) . Because β -gal has been so well studied as a quantitative reporter, we also tested the same promoters in a promoterless β -gal vector (6) to directly compare β -gal and GFP as reporters of promoter activity in E. coli . Here, we present the use of GFP as a rapid, simple and quantitative reporter of relative promoter activity in intact E. coli cells.
MATERIALS AND METHODS
Materials
We obtained DNA polymerase I (Klenow fragment), T4 DNA ligase, T4 polynucleotide kinase, TaqDNA polymerase, competent JM109 and a Wizard ® Midi Prep Kit from Promega (Madison, WI, USA), restriction endonucleases, λBst EII marker and calf intestinal alkaline phosphatase from New England Biolabs (Beverly, MA, USA) and oligonucleotides from Life Technologies (Gaithersburg, MD, USA).
Cell Growth Conditions
For the plasmid copy number assay and for the GFP and β -gal liquid culture assays, cells were grown at 37°C in M9 minimal medium (8) supplemented with 1% glucose, 0.2% casamino acids, 1 µ g/mL thiamine and 100 µ g/mL ampicillin. (From this point, we will refer to this supplemented medium as M9 Glu+Caa.) LB broth was unsuitable for GFP liquid culture assays because of its high and variable background fluorescence (data not shown). For GFP plate assays, single colonies were streaked on LB agar plates supplemented with 100 µ g/mL ampicillin, and plates were incubated at 37°C for 20 h followed by storage at 4°C.
Vectors
We obtained the pGFPuv plasmid from Clontech Laboratories (Palo Alto, CA, USA) and excised the lac promoter using Sap I and Hin dIII followed by
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